HilleVax, Inc. (HLVX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
HLVX currently has 50.1M outstanding shares. with moderate dilution risk from 11.8M authorized shares representing 23.6% potential dilution. The company has minimally diluted shareholders by 2.36% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 06, 2025 |
10-Q filing | 50.1M shares outstanding |
50M | 12M |
| May 08, 2025 |
10-Q filing | 50.0M shares outstanding |
50M | 12M |
| Mar 28, 2025 |
10-K filing | 49.2M shares outstanding |
49M | 12M |
| Nov 07, 2024 |
10-Q filing | 49.4M shares outstanding |
49M | 12M |
| Aug 09, 2024 |
10-Q filing | 49.2M shares outstanding |
49M | 12M |
| May 09, 2024 |
10-Q filing | 48.5M shares outstanding |
48M | 12M |
| Mar 20, 2024 |
10-K filing | 49.7M shares outstanding |
50M | 12M |
| Mar 20, 2024 |
S-3 filing: The company may offer and sell up to $500 million in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings. |
48M | 12M |
| Nov 09, 2023 |
10-Q filing | 48.4M shares outstanding |
48M | 12M |
| Aug 14, 2023 |
10-Q filing | 38.0M shares outstanding |
38M | 12M |
| Jun 13, 2023 |
8-K filing: The company's Board of Directors approved changes to the non-employee director compensation program, including initial and annual grants of options to purchase common stock. |
38M | 12M |
| May 12, 2023 |
S-3 filing: HeliosX is offering common stock, preferred stock, and debt securities under a shelf registration, with a specific offering of common stock having an aggregate offering price of up to $100 million through an at-the-market offering via Stifel. |
39M | 12M |
| May 12, 2023 |
10-Q filing | 37.8M shares outstanding |
38M | 12M |
| Mar 17, 2023 |
10-K filing | 39.3M shares outstanding |
39M | 12M |
| Nov 10, 2022 |
10-Q filing | 33.3M shares outstanding |
33M | 12M |
| Aug 10, 2022 |
10-Q filing | 33.4M shares outstanding |
33M | 12M |
| Jun 08, 2022 |
10-Q filing | 33.4M shares outstanding |
33M | 12M |
| Apr 25, 2022 |
S-1/A filing: This S-1/A filing outlines the initial public offering of HilleVax, Inc., involving 10,294,000 shares of common stock with an expected price between $16.00 and $18.00 per share, and grants underwriters an option to purchase up to 1,544,100 additional shares. |
N/A | 12M |
| Apr 18, 2022 |
S-1/A filing: Initial public offering of common stock by HilleVax, Inc. |
N/A | 0 |
| Apr 06, 2022 |
S-1 filing: This is an S-1 filing for an initial public offering of common stock by HilleVax, Inc. |
N/A | 0 |